Anebulo Pharmaceuticals, Inc. - ANEB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$91.56M
QoQ value delta ($000)
+$36.02M (+64.85%)
Implied price effect (QoQ)
+64.94%
Shares
Total shares
22,208,816
QoQ shares delta
-11,042 (-0.05%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ANEB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
22NW, LP 84,760 15,467,300 35.68%
Nantahala Capital Management, LLC 3,066 3,036,325 0.1%
MANGROVE PARTNERS IM, LLC 2,550 2,525,252 0.21%
VANGUARD GROUP INC 440 435,821 0.0%
MORGAN STANLEY 403 399,404 0.0%
GEODE CAPITAL MANAGEMENT, LLC 162 160,760 0.0%
Rangeley Capital, LLC 50 50,000 0.04%
RENAISSANCE TECHNOLOGIES LLC 25 25,098 0.0%
CITADEL ADVISORS LLC 24 24,239 0.0%
BlackRock, Inc. 24 23,790 0.0%
NORTHERN TRUST CORP 22 21,994 0.0%
Ikarian Capital, LLC 17 17,736 0.0%
STATE STREET CORP 12 12,768 0.0%
Tower Research Capital LLC (TRC) 3 3,230 0.0%
JPMORGAN CHASE & CO 2 2,253 0.0%
UBS Group AG 2 2,334 0.0%
BANK OF AMERICA CORP /DE/ 0 382 0.0%
ROYAL BANK OF CANADA 0 30 0.0%
FNY Investment Advisers, LLC 0 100 0.0%